Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,424 | 286 | 457 | 115 | 337 |
| Receivables | N/A | 7 | 9 | 4 | 22 |
| Other current assets | 0 | 833 | 0 | 0 | 2 |
| TOTAL | $4,443 | $1,152 | $484 | $165 | $396 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 0 | 1 | 1 |
| Intangibles | 2,039 | 0 | 0 | 0 | 0 |
| TOTAL | $2,040 | $1 | $0 | $1 | $1 |
| Total Assets | $6,483 | $1,153 | $484 | $165 | $397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 992 | 919 | 592 | 641 | 532 |
| Other current liabilities | 30 | 100 | 585 | N/A | N/A |
| TOTAL | $1,022 | $1,019 | $1,177 | $641 | $532 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,022 | $1,019 | $1,177 | $641 | $532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 13 | 59 | 57 | N/A |
| Common Shares | 3 | 2 | 16 | 14 | 2 |
| Retained earnings | -4,811 | -3,965 | -3,620 | -3,196 | -2,639 |
| Other shareholders' equity | -10 | -10 | -11 | -7 | -12 |
| TOTAL | $5,461 | $134 | $-692 | $-475 | $-135 |
| Total Liabilities And Equity | $6,483 | $1,153 | $484 | $165 | $397 |